Stock DNA GINO BIOW
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company GINO BIOW Nasdaq

Equities

DNA

US37611X1000

Biotechnology & Medical Research

Business Summary

Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It also focuses on the design of next-generation cell therapies for autoimmune diseases. It uses its platform to develop and screen libraries of novel NK-specific and T-cell specific chimeric antigen receptor and switch receptor designs, which enable control and performance of immune cell-based therapies.

Number of employees: 1,218

Sales per Business

USD in Million2022Weight2023Weight Delta
Cell Engineering
57.1 %
144 30.1 % 144 57.1 % -0.09%
Biosecurity
42.9 %
334 69.9 % 108 42.9 % -67.69%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
478 100.0 % 251 100.0 % -47.36%

Managers

Managers TitleAgeSince
Austin Che FOU
 Founder - 07-12-31
Bartholomew Canton FOU
 Founder - 07-12-31
Reshma Shetty FOU
 Founder 43 07-12-31
Jason Kelly FOU
 Founder 43 07-12-31
Mark Dmytruk DFI
 Director of Finance/CFO 53 21-09-15
Steven Coen AUD
 Comptroller/Controller/Auditor 58 23-05-14
Karen Tepichin LAW
 General Counsel - -

Members of the board

Members of the board TitleAgeSince
Christian Henry BRD
 Director/Board Member 56 21-09-15
Marijn Dekkers CHM
 Chairman 65 21-09-15
Kathy Hannan BRD
 Director/Board Member 62 22-08-01
Harry Sloan BRD
 Director/Board Member 74 21-09-15
Jason Kelly FOU
 Founder 43 07-12-31
Reshma Shetty FOU
 Founder 43 07-12-31
Reshma Kewalramani BRD
 Director/Board Member 51 21-09-15
Shyam Sankar BRD
 Director/Board Member 42 21-09-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 120,000,000 0 0 66.98 %
Stock B 10 404,337,677 0 22,851,000 ( 5.651 %)
Stock C 1 1,765,736,109 1,533,858,052 ( 86.87 %) 114,827,000 ( 6.503 %)

Shareholders

NameEquities%Valuation
Baillie Gifford & Co.
14.31 %
236,292,183 14.31 % 274 M $
ARK Investment Management LLC
11.48 %
189,606,908 11.48 % 220 M $
Cascade Investment LLC
9.199 %
151,865,481 9.199 % 176 M $
Viking Global Investors LP
8.667 %
143,085,126 8.667 % 166 M $
Vanguard Fiduciary Trust Co.
8.043 %
132,780,095 8.043 % 154 M $
BlackRock Advisors LLC
4.264 %
70,392,839 4.264 % 82 M $
Anchorage Capital Group LLC
4.231 %
69,854,593 4.231 % 81 M $
Thomas Knight
4.139 %
68,328,434 4.139 % 79 M $
Nikko Asset Management Americas, Inc.
3.528 %
58,238,915 3.528 % 68 M $
Morgan Stanley Investment Management, Inc.
3.009 %
49,681,887 3.009 % 58 M $
NameEquities%Valuation
Viking Global Investors LP
27.78 %
80,000,000 27.78 % 93 M $
NameEquities%Valuation
LMR Partners LLP
-
2,365,816 - 212 923 $
Walleye Capital LLC
-
1,646,466 - 148 182 $
Cowen & Co. LLC
-
927,569 - 83 481 $
Altshuler Shaham Investments House Ltd.
-
576,345 - 51 871 $
Ionic Capital Management LLC
-
348,234 - 31 341 $
Walleye Trading LLC
-
156,312 - 14 068 $
Shay Capital LLC
-
127,596 - 11 484 $
Chescapmanager LLC
-
103,521 - 9 317 $
D.E. Shaw & Co., Inc.
-
71,236 - 6 411 $
Security Benefit Life Insurance Co. (Invt Port)
-
64,709 - 5 824 $
NameEquities%Valuation
Reshma Shetty
15.70 %
85,659,550 15.70 % 99 M $
Jason Kelly
14.97 %
81,657,653 14.97 % 95 M $
Austin Che
14.69 %
80,147,413 14.69 % 93 M $
Bartholomew Canton
14.34 %
78,235,274 14.34 % 91 M $
Thomas Knight
1.644 %
8,972,183 1.644 % 10 M $
Mark Dmytruk
0.1152 %
628,685 0.1152 % 729 275 $
Marie Fallon
0.0246 %
133,991 0.0246 % 155 430 $

Holdings

NameEquities%Valuation
MICROBA LIFE SCIENCES LIMITED
2.58%
 11,535,246 2.58% 1,580,329 $
SYNLOGIC, INC.
3.63%
 422,720 3.63% 756,669 $

Company contact information

Ginkgo Bioworks Holdings, Inc.

27 Drydock Avenue 8th floor

02210, Boston

+

http://www.ginkgobioworks.com
address GINO BIOW(DNA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.82% 41.35B
LONZA GROUP AG Stock Lonza Group AG
+43.06% 40.38B
MODERNA, INC. Stock Moderna, Inc.
+2.56% 39.05B
CELLTRION, INC. Stock Celltrion, Inc.
-12.11% 26.67B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+3.09% 24.07B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.16% 18.36B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+22.12% 11.6B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.74% 11.68B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.75% 11.15B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. DNA Stock
  4. DNA Stock
  5. Company GINO BIOW